Have your say on the Federal Register of Legislation. Complete our annual survey and tell us about your experience using the Register. The survey closes on 28 November 2026.
This item is authorised by the following title:
National Health Legislation Amendment (Maximum Dispensed Quantities) Instrument 2024 (PB 14 of 2024 | F2024L00236)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2024 (No. 2) (PB 15 of 2024 | F2024L00237)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2024 (No. 1) (PB 1 of 2024 | F2024L00119)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 13) (PB 128 of 2023 | F2023L01747)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 12) (PB 112 of 2023 | F2023L01575)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 11) (PB 105 of 2023 | F2023L01452)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 10) (PB 91 of 2023 | F2023L01331)
National Health Legislation Amendment (Opioid Dependence Treatment and Maximum Dispensed Quantities) Instrument 2023 (PB 57 of 2023 | F2023L00843)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 8) (PB 79 of 2023 | F2023L01147)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 9) (PB 86 of 2023 | F2023L01154)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 7) (PB 67 of 2023 | F2023L01051)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 6) (PB 54 of 2023 | F2023L00910)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 5) (PB 43 of 2023 | F2023L00646)
View Explanatory Statement/s